Q-Bank Breakdown: Opioid use disorder (naloxone, methadone) — Why Every Answer Choice Matters

Opioid questions on the USMLE love to do one thing: force you to treat the patient in front of you—not the diagnosis you wish they had. If you can recognize opioid intoxication vs opioid withdrawal vs opioid use disorder (OUD) maintenance, then naloxone, methadone, buprenorphine, clonidine, and naltrexone stop feeling like random buzzwords and start feeling like a clean algorithm.

---

Clinical Vignette (Q-Bank Style)

A 28-year-old man is brought to the ED after being found unresponsive in a bathroom. A friend reports he “uses heroin sometimes.” On arrival, the patient is somnolent and difficult to arouse. Vitals: T 36.8°C (98.2°F), HR 54/min, BP 96/58 mmHg, RR 6/min, SpO₂ 84% on room air. Pupils are pinpoint. Lung exam shows shallow respirations without wheezes.

Which of the following is the most appropriate next step in management?

A. Administer intranasal naloxone
B. Start methadone maintenance therapy
C. Administer clonidine
D. Administer naltrexone
E. Administer flumazenil

---

Step-by-Step: Identify the Syndrome First

This is opioid intoxication/overdose:

• CNS depression: somnolent/unresponsive
• Respiratory depression: RR 6/min + low O₂ saturation
• Miosis: pinpoint pupils
• Often bradycardia/hypotension

The immediate threat is death from hypoventilation, so treat airway/breathing and reverse opioid effect.

---

Correct Answer: A. Administer intranasal naloxone

Why it’s correct

Naloxone is a competitive opioid receptor antagonist (highest affinity for $\mu$ receptors). It rapidly reverses opioid-induced respiratory depression.

High-yield naloxone facts (USMLE favorites):

• Indication: suspected opioid overdose with respiratory depression (or significant CNS depression)
• Routes: IV, IM, intranasal
• Onset: minutes
• Duration is shorter than many opioids → renarcotization can occur
  • Patients may require repeat dosing or continuous infusion
• Can precipitate acute withdrawal in dependent patients (agitation, pain, vomiting, diarrhea, piloerection)

Practical ED logic

1. Support ventilation (bag-mask, oxygen) as needed
2. Naloxone now (don’t wait for tox screens)
3. Observe for recurrence; consider longer monitoring for long-acting opioids

---

Why Every Other Answer Choice Is Wrong (and When It Would Be Right)

B. Start methadone maintenance therapy

Why it’s wrong here:
Methadone is used for maintenance treatment of OUD and withdrawal management, not for acute overdose reversal. It’s a full $\mu$-agonist—giving it now could worsen respiratory depression.

When methadone is right:

• Patient is stable (not in respiratory failure) and you’re treating OUD long-term or managing withdrawal
• Used in opioid treatment programs (OTPs)

Methadone high-yield:

• Full agonist → reduces cravings/withdrawal
• QT prolongation/torsades risk (ECG considerations)
• Overdose risk is real, especially during initiation/titration

---

C. Administer clonidine

Why it’s wrong here:
Clonidine (an $\alpha_2$-agonist) helps opioid withdrawal symptoms, not overdose. This patient is intoxicated with life-threatening respiratory depression.

When clonidine is right:

• Symptomatic treatment for opioid withdrawal (especially autonomic symptoms):
  • sweating, tachycardia, hypertension, anxiety, restlessness

Classic withdrawal vs intoxication clue:

• Withdrawal: mydriasis, yawning, lacrimation, rhinorrhea, diarrhea, piloerection, tachycardia, hypertension
• Intoxication: miosis, bradycardia, hypotension, respiratory depression

---

D. Administer naltrexone

Why it’s wrong here:
Naltrexone is a long-acting opioid antagonist used for relapse prevention after detox, not for acute overdose in the ED. In an opioid-dependent person, it can precipitate sustained, severe withdrawal.

When naltrexone is right:

• Patient has completed detox and is opioid-free (commonly ~7–10 days)
• Used for:
  • OUD relapse prevention
  • Alcohol use disorder (reduces craving/reward)

High-yield pitfall:
Starting naltrexone too early → sudden withdrawal + poor adherence.

---

E. Administer flumazenil

Why it’s wrong here:
Flumazenil reverses benzodiazepines, not opioids. This vignette screams opioid toxicity (miosis + respiratory depression).

When flumazenil is right (rarely):

• Iatrogenic benzodiazepine overdose (e.g., procedural sedation) in a patient without:
  • chronic benzo use (withdrawal seizures risk)
  • seizure disorder
  • co-ingestion of pro-convulsant agents (e.g., TCAs)

USMLE pearl: flumazenil is not a benign “benzo naloxone”—it can provoke seizures.

---

The Core Algorithm (How to Think on Test Day)

If you see opioid overdose/intoxication

• Respiratory depression + CNS depression ± miosis
• Treat:
  • Airway/breathing support
  • Naloxone
  • Monitor/repeat dosing due to short half-life

If you see opioid withdrawal

• No respiratory depression; patient is uncomfortable but usually not dying
• Treat options:
  • Buprenorphine (partial agonist) or methadone (full agonist) for withdrawal/OUD treatment
  • Clonidine for autonomic symptoms (supportive)

If you see OUD long-term treatment

• Methadone (full agonist, OTP)
• Buprenorphine (partial agonist; office-based prescribing; often combined with naloxone)
• Naltrexone (antagonist; must be detoxed first)

---

High-Yield Medication Table (Quick Comparison)

---

Rapid-Fire USMLE Clues You Should Memorize

Opioid intoxication

• Triad: CNS depression + respiratory depression + miosis
• Antidote: naloxone

Opioid withdrawal

• “Flu-like” + GI upset + autonomic activation:
  • mydriasis, diarrhea, yawning, lacrimation, piloerection, tachycardia
• Treatment: buprenorphine/methadone (preferred) or clonidine (symptomatic)

Buprenorphine precipitated withdrawal

• Happens when buprenorphine is started too soon after a full agonist (e.g., heroin, oxycodone, methadone)
• Why: high receptor affinity displaces full agonist but only partially activates receptor

---

Takeaway: The “Most Appropriate Next Step” Is About Physiology, Not Labels

When the stem gives you RR 6/min and SpO₂ 84% with pinpoint pupils, you’re not being asked about “treating addiction.” You’re being asked how to stop the patient from dying in the next 5 minutes: naloxone + ventilatory support, then reassess and plan for OUD treatment afterward.